Healthcare -
Biotechnology - NASDAQ - US
$ 6.42
1.42 %
$ 570 M
Market Cap
-2.73
P/E
VERV - CAPITAL EXPENDITURES
Capital Expenditures VERV - Verve Therapeutics, Inc.
-9.28 M
LAST VALUE
-45.93%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR